|
Mutation Information
|
Mutation Site
|
M204I |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Genotype/Subtype
|
C |
|
Relevant Drug
|
tenofovir (TDF);entecavir (ETV) |
|
Country
|
Korea |
Literature Information
|
PubMed PMID
|
31543688
|
|
Disease
|
Chronic hepatitis B
|
|
Published Year
|
2019 |
|
Journal
|
World journal of gastroenterology |
|
Title
|
Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations. |
|
Author
|
Choe WH,Kim K,Lee SY,Choi YM,Kwon SY,Kim JH,Kim BJ |
|
Evidence
|
Tenofovir is a more suitable treatment than entecavir forChronic hepatitis Bpatients carrying naturally occurring rtM204I mutations.
|
|
|
HBV Mutation Detail Information